370 related articles for article (PubMed ID: 22952421)
1. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
[TBL] [Abstract][Full Text] [Related]
2. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.
Yang XH; Flores LM; Li Q; Zhou P; Xu F; Krop IE; Hemler ME
Cancer Res; 2010 Mar; 70(6):2256-63. PubMed ID: 20197472
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD151 plays a key role in skin squamous cell carcinoma.
Li Q; Yang XH; Xu F; Sharma C; Wang HX; Knoblich K; Rabinovitz I; Granter SR; Hemler ME
Oncogene; 2013 Apr; 32(14):1772-83. PubMed ID: 22824799
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
[TBL] [Abstract][Full Text] [Related]
5. ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation.
Kedrin D; Wyckoff J; Boimel PJ; Coniglio SJ; Hynes NE; Arteaga CL; Segall JE
Clin Cancer Res; 2009 Jun; 15(11):3733-9. PubMed ID: 19458057
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
7. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.
Yang XH; Richardson AL; Torres-Arzayus MI; Zhou P; Sharma C; Kazarov AR; Andzelm MM; Strominger JL; Brown M; Hemler ME
Cancer Res; 2008 May; 68(9):3204-13. PubMed ID: 18451146
[TBL] [Abstract][Full Text] [Related]
8. Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.
Palmer TD; Martínez CH; Vasquez C; Hebron KE; Jones-Paris C; Arnold SA; Chan SM; Chalasani V; Gomez-Lemus JA; Williams AK; Chin JL; Giannico GA; Ketova T; Lewis JD; Zijlstra A
Cancer Res; 2014 Jan; 74(1):173-87. PubMed ID: 24220242
[TBL] [Abstract][Full Text] [Related]
9. CD151 represses mammary gland development by maintaining the niches of progenitor cells.
Yin Y; Deng X; Liu Z; Baldwin LA; Lefringhouse J; Zhang J; Hoff JT; Erfani SF; Rucker EB; O'Connor K; Liu C; Wu Y; Zhou BP; Yang XH
Cell Cycle; 2014; 13(17):2707-22. PubMed ID: 25486358
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
11. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
12. Key Role of CD151-integrin Complex in Lung Cancer Metastasis and Mechanisms Involved.
Peng D; Li PC; Liu T; Zeng HS; Fei YJ; Liu ZX; Zuo HJ
Curr Med Sci; 2020 Dec; 40(6):1148-1155. PubMed ID: 33428143
[TBL] [Abstract][Full Text] [Related]
13. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
14. Deletion of tetraspanin CD151 alters the Wnt oncogene-induced mammary tumorigenesis: A cell type-linked function and signaling.
Li H; Li J; Han R; Deng X; Shi J; Huang H; Hamad N; McCaughley A; Liu J; Wang C; Chen K; Wei D; Qiang J; Thatcher S; Wu Y; Liu C; Thibault O; Wei X; Chen S; Qian H; Zhou BP; Xu P; Yang XH
Neoplasia; 2019 Dec; 21(12):1151-1163. PubMed ID: 31783316
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.
Zevian S; Winterwood NE; Stipp CS
J Biol Chem; 2011 Mar; 286(9):7496-506. PubMed ID: 21193415
[TBL] [Abstract][Full Text] [Related]
16. Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells.
Mieszkowska M; Piasecka D; Potemski P; Debska-Szmich S; Rychlowski M; Kordek R; Sadej R; Romanska HM
Transl Res; 2019 May; 207():44-55. PubMed ID: 30639369
[TBL] [Abstract][Full Text] [Related]
17. A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5.
Winterwood NE; Varzavand A; Meland MN; Ashman LK; Stipp CS
Mol Biol Cell; 2006 Jun; 17(6):2707-21. PubMed ID: 16571677
[TBL] [Abstract][Full Text] [Related]
18. The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms.
Gustafson-Wagner E; Stipp CS
PLoS One; 2013; 8(4):e61834. PubMed ID: 23613949
[TBL] [Abstract][Full Text] [Related]
19. Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.
Strecker TE; Shen Q; Zhang Y; Hill JL; Li Y; Wang C; Kim HT; Gilmer TM; Sexton KR; Hilsenbeck SG; Osborne CK; Brown PH
J Natl Cancer Inst; 2009 Jan; 101(2):107-13. PubMed ID: 19141783
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin CD151 and integrin α3β1 contribute to the stabilization of integrin α6β4-containing cell-matrix adhesions.
Te Molder L; Juksar J; Harkes R; Wang W; Kreft M; Sonnenberg A
J Cell Sci; 2019 Oct; 132(19):. PubMed ID: 31488507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
